Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. Atrion is a manufacturer of specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables.
|Headquarters||1 Allentown Pkwy|
ALLEN, TX, United States 75002-4206
|Chairman of the Board||Emile Battat|
|President, Chief Executive Officer||David Battat|
|Chief Financial Officer, Vice President, Treasurer, Secretary||Jeffery Strickland|
|Lead Independent Director||Roger Stebbing|
|Independent Director||Hugh Morgan|
|Shares Out.||1.8M||Book Value||$89.36|
|Annual Dividend Rate||4.20 USD||Price/Sales (TTM)||6.2|
|Ex-Div Date||11/29/16||P/Cash Flow (TTM)||31.2x|
|Pay Date||12/15/16||Operating Margin||27.27%|
*GAAP = prior to non-GAAP analyst adjusted earnings.